114 related articles for article (PubMed ID: 4367158)
1. Transformation of nonhuman primate lymphocytes by Epstein-Barr virus.
Deinhardt F; Falk LA; Wolfe LG
Cancer Res; 1974 May; 34(5):1241-4. PubMed ID: 4367158
[No Abstract] [Full Text] [Related]
2. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro.
Kirchner H; Tosato G; Blaese RM; Broder S; Magrath IT
J Immunol; 1979 Apr; 122(4):1310-3. PubMed ID: 221572
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus: transformation of non-human primate lymphocytes in vitro.
Falk L; Wolfe L; Deinhardt F; Paciga J; Dombos L; Klein G; Henle W; Henle G
Int J Cancer; 1974 Mar; 13(3):363-76. PubMed ID: 4362611
[No Abstract] [Full Text] [Related]
4. Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus.
Robinson JE; Brown N; Andiman W; Halliday K; Francke U; Robert MF; Andersson-Anvret M; Horstmann D; Miller G
N Engl J Med; 1980 Jun; 302(23):1293-7. PubMed ID: 6245364
[No Abstract] [Full Text] [Related]
5. Herpesvirus ateles: transformation in vitro of marmoset splenic lymphocytes.
Falk L; Wright J; Wolfe L; Deinhardt F
Int J Cancer; 1974 Aug; 14(2):244-51. PubMed ID: 4376514
[No Abstract] [Full Text] [Related]
6. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
Tsukuda K; Berczi I; Klein G
J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
[TBL] [Abstract][Full Text] [Related]
7. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
Klein G; Purtilo D
Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
[No Abstract] [Full Text] [Related]
8. In vitro and in vivo studies with Epstein-Barr virus (EBV). A review.
Dunkel VC
Ann Clin Lab Sci; 1973; 3(6):424-8. PubMed ID: 4356929
[No Abstract] [Full Text] [Related]
9. B cells under influence: transformation of B cells by Epstein-Barr virus.
Küppers R
Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
[TBL] [Abstract][Full Text] [Related]
10. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
Bachmann AE; Giraudo Conesa LC; Braun M
Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
[No Abstract] [Full Text] [Related]
11. New oncologic associations for the Epstein-Barr virus.
Gartner JG; Seemayer TA
Am J Surg Pathol; 1982 Jul; 6(5):471-3. PubMed ID: 6289684
[No Abstract] [Full Text] [Related]
12. Review of the clinical manifestations, laboratory findings, and complications of infectious mononucleosis.
White LR; Karofsky PS
Wis Med J; 1985 Dec; 84(12):19-25. PubMed ID: 3002047
[No Abstract] [Full Text] [Related]
13. [Serological investigation of Epstein-Barr virus antibodies and heterophile antibodies of childhood in Kumamoto Prefecture (author's transl)].
Kumagai E; Katsuki T
Rinsho Byori; 1981 Jun; 29(6):617-21. PubMed ID: 6279939
[No Abstract] [Full Text] [Related]
14. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
[TBL] [Abstract][Full Text] [Related]
15. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.
Nemerow GR; McNaughton ME; Cooper NR
Trans Assoc Am Physicians; 1985; 98():290-300. PubMed ID: 3022444
[No Abstract] [Full Text] [Related]
17. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
Thorley-Lawson DA
J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
[TBL] [Abstract][Full Text] [Related]
18. [Epstein-Barr virus and its role in various rheumatic diseases].
Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
[No Abstract] [Full Text] [Related]
19. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Perkins S; Foung SK
Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
[No Abstract] [Full Text] [Related]
20. Relative lack of Epstein Barr virus (EBV) receptors on B cells from persistently EBV seronegative adults.
Gervais F; Wills A; Leyritz M; Lebrun A; Joncas JH
J Immunol; 1981 Mar; 126(3):897-900. PubMed ID: 6257786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
